Corporate Compliance Partners Corporate Compliance Partners
 Whistleblower Experts
 Sarbanes-Oxley News & Developments
Site Map  >  Privacy Policy  >  Contact Us  
Sarbanes-Oxley Bill We Can Help You The Compliance Network About Us
> News & Developments <

Sarbanes-Oxley News & Developments

Pfizer settles fraud case for $430 million

The penalties include a $240 million criminal fine.

> > Pharmaceutical giant Pfizer agreed to pay $430 million and plead guilty to charges that its epilepsy drug, Neurontin, was marketed for uses unapproved by the federal government.
Source: USA Today


Published:2004-05-17
Subscribe to the CCP Report, our free weekly newsletter about SOX! Your Email Address:

 More Resources

More News

The View from the Other Side
Can IT live up to the expectations for governance, compliance, and revenue generation of a CFO?

Capital Markets Report Urges 404 Fixes
A panel says changes in the way Sarbanes-Oxley has been applied will improve the competitiveness of the U.S. capital markets.

Wal-Mart Whistleblower Drops Lawsuit
Former executive still has a whistleblower case pending before the Labor Department.

All News
Sarbanes-Oxley Act SEC Rules Exchange Rules

> Public Accounting oversight board (101)
> Audit Committee responsibilities (301(2))
> Independence (301(3))
> Complaints (301(4))
> Advisors (301(5))
> Funding (301(6))
> Protections (806)
> Retaliation (1107)
> SEC Rules and Regulations
> SEC Proposed Rules
> SEC Final Rules Releases
> SEC Concept Releases
> SRO Rulemaking
> SEC Interpretive Releases
> SEC Policy Statements
> PCAOB Rulemaking
> NYSE & NASDAQ Rules
> OSHA Rules


>  The View from the Other Side
Can IT live up to the expectations for governance, compliance, and revenue generation of a CFO?

> More News
Sarbanes-Oxley Bill | Are You Compliant? | We Can Help You | About Us
Home | Site Map | Contact Us | Privacy Policy

For more information, please contact us at ccp@answernet.com
AnswerNet © - All rights reserved.